Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement | Blood Cancer Journal
Cancers | Free Full-Text | Immunoglobulin M Paraproteinaemias
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study - The Lancet
Monoclonal Gammopathy of Undetermined Significance | IntechOpen
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance | NEJM
Monoclonal gammopathy of undetermined significance - Kyle - 2006 - British Journal of Haematology - Wiley Online Library
Neuropathy associated with IgA monoclonal Gammopathy. A harbinger of AL amyloidosis - Journal of the Neurological Sciences
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma - ScienceDirect
Comparison of MGUS and multiple myeloma variants | Download Table
Monoclonal gammopathy of undetermined significance: A primary care guide | Cleveland Clinic Journal of Medicine
Risk Stratifying Patients with Monoclonal Gammopathy of Undetermined Significance – Consult QD
IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration | SpringerLink
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS) | Blood Cancer Journal
Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance | Bone Marrow Transplantation
Prevalence of Monoclonal Gammopathy of Undetermined Significance | NEJM
Monoclonal gammopathy of renal significance: Early diagnosis is key - ScienceDirect
Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis | SpringerLink
IJMS | Free Full-Text | Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma
2ww referral Routine referral / Haem A&G Annual monitoring in primary care Local Guidance for managing MGUS for primary care
What is the significance of monoclonal gammopathy of undetermined significance? | RCP Journals
Myeloma Explained | Haematology | Oncology | onthewards
Management of Monoclonal Gammopathy of Uncertain Significance | SpringerLink
Monoclonal Gammopathies of Undetermined Significance (MGUS): Practice Essentials, Pathophysiology, Epidemiology
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
MGUS Predicts Worse Prognosis in Patients with Coronary Artery Disease | SpringerLink
